Why the study?
Heparin-induced thrombocytopenia is a potentially fatal complication of heparin therapy, particularly during extracorporeal mechanical support requiring anticoagulation.
Managing heparin-induced thrombocytopenia in patients requiring multiple extracorporeal mechanical supports is highly complex and carries risks of both bleeding and thrombosis.
Alerts clinicians to HIT in ECMO/CRRT with thrombocytopenia and occlusions; leaves optimal anticoagulation open for study.
Heparin-induced thrombocytopenia (HIT) is a potentially fatal complication of heparin therapy, particularly during extracorporeal mechanical support requiring anticoagulation. We report the case of a 57-year-old woman with fulminant myocarditis complicated by acute kidney injury who was transferred while receiving extracorporeal membrane oxygenation and continuous renal replacement therapy with unfractionated heparin. After transfer, a rapid platelet decline and repeated circuit occlusions raised a strong suspicion of HIT based on the 4Ts score. Heparin was replaced with nafamostat mesilate or argatroban, and HIT antibodies were detected. Both bleeding and thrombotic complications occurred during intensive care, thus reflecting the complexity of managing critically ill patients receiving multiple extracorporeal mechanical supports.
No takes yet. Share an insight, caveat, or question.
Morita et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: